enGene Therapeutics Inc.
ENGN- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001980845
In the last 90 days, enGene Therapeutics Inc. insiders filed 1 open-market purchase and 0 sales; 60 institutions reported holding it in 13F filings for Q2 2026, worth $86.5M in total; no superinvestor holds it.
Other share classesENGNW
13F holders, Q2 2025
Institutional positions in enGene Therapeutics Inc. as of Jun 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 36
- +5 vs. Q1 2025
- Shares held
- 40.4M
- −530.9K (−1.3%) vs. Q1 2025
- Total value
- $147.1M
- −$36.3M (−19.8%) vs. Q1 2025
- New holders
- 8
- 4 more added
- Sold out
- 3
- 9 more reduced
Compare with Q1 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ENGN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 60 | $86.5M |
| Q1 2026 | 62 | $383.0M |
| Q4 2025 | 58 | $530.8M |
| Q3 2025 | 37 | $279.1M |
| Q2 2025 | 36 | $147.1M |
| Q1 2025 | 31 | $183.4M |
| Q4 2024 | 34 | $274.7M |
| Q3 2024 | 30 | $227.7M |
| Q2 2024 | 30 | $307.1M |
| Q1 2024 | 31 | $536.1M |
| Q4 2023 | 11 | $130.9M |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2025
Shares, value and share of portfolio for each institution holding enGene Therapeutics Inc.; share changes are against Q1 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| FCPM III Services B.V. | 9,632,561 | $35.1M | 9.50% | 00.0% | Unchanged |
| VR Adviser, LLC | 5,046,414 | $18.4M | 1.38% | 00.0% | Unchanged |
| Kynam Capital Management, LP | 4,994,090 | $18.2M | 1.96% | 00.0% | Unchanged |
| Deep Track Capital, LP | 4,557,575 | $16.6M | 0.53% | 00.0% | Unchanged |
| Blue Owl Capital Holdings LP | 3,728,106 | $13.6M | 4.38% | +448,728+13.7% | Added |
| Cormorant Asset Management, LP | 2,323,595 | $8.46M | 0.63% | 00.0% | Unchanged |
| Bank of America Corp | 2,005,708 | $7.30M | 0.00% | 00.0% | Unchanged |
| Point72 Asset Management, L.P. | 1,208,299 | $4.40M | 0.01% | −32,889−2.6% | Reduced |
| Franklin Resources Inc | 1,038,000 | $3.78M | 0.00% | −136,866−11.6% | Reduced |
| Adage Capital Partners GP, L.L.C. | 1,000,000 | $3.64M | 0.01% | −571,642−36.4% | Reduced |
| Goldman Sachs Group Inc | 899,086 | $3.27M | 0.00% | 00.0% | Unchanged |
| Sr One Capital Management, LP | 747,750 | $2.72M | 0.59% | 00.0% | Unchanged |
| OrbiMed Advisors LLC | 677,977 | $2.47M | 0.06% | −213,639−24.0% | Reduced |
| Omega Fund Management, LLC | 526,357 | $1.92M | 1.24% | 00.0% | Unchanged |
| Sphera Funds Management Ltd. | 504,409 | $1.84M | 0.48% | −23,956−4.5% | Reduced |
| Vestal Point Capital, LP | 370,000 | $1.35M | 0.07% | 00.0% | Unchanged |
| Morgan Stanley | 352,768 | $1.28M | 0.00% | −83,796−19.2% | Reduced |
| Marshall Wace, LLP | 343,928 | $1.25M | 0.00% | −1,469−0.4% | Reduced |
| Schonfeld Strategic Advisors LLC | 174,570 | $635.4K | 0.00% | +40,486+30.2% | Added |
| Affinity Asset Advisors, LLC | 77,000 | $280.3K | 0.04% | +77,000 | New |
| Northern Trust Corp | 33,026 | $120.2K | 0.00% | −816−2.4% | Reduced |
| Geode Capital Management, LLC | 29,018 | $105.6K | 0.00% | 00.0% | Unchanged |
| ADAR1 Capital Management, LLC | 27,787 | $101.1K | 0.02% | +3,988+16.8% | Added |
| Citadel Advisors LLC | 23,043 | $83.9K | 0.00% | +23,043 | New |
| Pale Fire Capital SE | 17,254 | $62.8K | 0.01% | 00.0% | Unchanged |
| Toronto Dominion Bank | 14,537 | $52.9K | 0.00% | 00.0% | Unchanged |
| Millennium Management LLC | 13,030 | $47.4K | 0.00% | +13,030 | New |
| Renaissance Technologies LLC | 11,400 | $41.5K | 0.00% | +11,400 | New |
| Paloma Partners Management Co | 10,319 | $37.6K | 0.01% | +10,319 | New |
| Royal Bank of Canada | 7,915 | $29.0K | 0.00% | 00.0% | Unchanged |
| Wolverine Asset Management LLC | 6,361 | $23.2K | 0.00% | +6,361 | New |
| Wells Fargo & Company | 3,199 | $11.6K | 0.00% | +1,278+66.5% | Added |
| MAI Capital Management | 2,925 | $10.6K | 0.00% | −75,142−96.3% | Reduced |
| Raymond James Financial Inc | 2,068 | $7.53K | 0.00% | +2,068 | New |
| NBC Securities, Inc. | 380 | $1.00K | 0.00% | +380 | New |
| SBI Securities Co., Ltd. | 30 | $109 | 0.00% | 00.0% | Unchanged |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −15,832−100.0% | Sold out |
| Sectoral Asset Management Inc | 0 | $0 | 0.00% | −11,700−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −1,200−100.0% | Sold out |